TokenPost·
Heron Therapeutics Q3 Net Revenue Falls 7.8% as Net Loss Narrows
Net loss declined to $5 million from $17.5 million a year earlier. CorMedix Therapeutics agreed to acquire substantially all of Heron's assets.
More news
- UnchainedElizabeth Warren Targets Trump Family Crypto Firms in Her Banking Committee Oversight List
- TokenPostGoldman Sachs Flags Nasdaq-100 Trend Line After Four Weekly Declines
- crypto.newsBlackRock sees record Bitcoin whale demand for IBIT conversions despite ETF outflows
- TokenPostBackpack Wallet Adds TRON Support for USDT Transfers and DeFi Access
- CointelegraphBitcoin price eyes $74K as Fed rate-hike bets hit 96% after Waller speech
- TokenPostKinetiq Launches Elysium Mainnet With 100-Millisecond Blocks